Lightbridge Corp reported holding approximately $215.7 million in cash as of March 31, 2026, an increase from $201.9 million at the end of 2025, attributed to raising $18.6 million through an equity ...
Company announcement - No. 10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metab ...
Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...
The article explains how safe harbour rules simplify transfer pricing compliance. It highlights that eligible transactions ...